ArticleJournal of mood and anxiety disorders2025
Associations between PACAP levels and psychophysiological indicators of fear and arousal in adults with posttraumatic stress symptoms.
Article in Journal of mood and anxiety disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lateral septal PACAP signaling regulates stress and anxiety reactions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Article
- The ventral hippocampus to paraventricular thalamus circuit regulates context-dependent hyperlocomotion through PAC1 receptor signaling in the chronic stress-induced PTSD mouse model.Translational psychiatry · 2026Article
- Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posttraumatic stress disorder (PTSD) is associated with heightened fear responding and decreased fear regulation, as demonstrated with psychophysiological measures (e.g., autonomic function) and circulating biomarkers of stress, such as pituitary adenylate cyclase-activating polypeptide (PACAP). The current study examined associations between PACAP levels and psychophysiological indicators of arousal in a sample of 168 trauma-exposed adults with a range of PTSD symptoms. We also examined sex differences in these relationships. Psychophysiological indicators included fear-potentiated startle (FPS), heart rate (HR), and heart rate variability (HRV) during a fear acquisition and extinction paradigm. PACAP levels were derived from fasting blood samples. PACAP levels were positively correlated with FPS during acquisition and HR during extinction, and negatively correlated with HRV during extinction. There were no significant PACAP-by-sex interaction effects in FPS, HR, or HRV models. Our results in the total sample are consistent with prior work demonstrating associations between PACAP and psychophysiological arousal. They add to previous evidence that circulating PACAP levels are associated with biological markers of centromedial amygdala-dependent functioning. Future research is needed among larger samples, including longitudinal designs to better determine causal relationships between PACAP levels and fear-related arousal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.